Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 8/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.55 |
| ▸ | MAPT | P10636 | 5/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 6/20 | 0.52 |
| ▸ | ATM | Q13315 | 2/20 | 0.52 |
| ▸ | STAT3 | P40763 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.49 |
| ▸ | NFKB2 | Q00653 | 3/20 | 0.49 |
| ▸ | RELA | Q04206 | 3/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | CASP3 | P42574 | 2/20 | 0.48 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16769394 | 1.00 | RAB9A (0.55) | RAB9ASMN1; SMN2MAPTALDH1A1MEN1 | |
| SCHEMBL11976546 | 0.94 | RAB9A (0.50) | RAB9ASMN1; SMN2MAPTALDH1A1MEN1 | |
| SCHEMBL11976542 | 0.92 | RAB9A (0.59) | RAB9ASMN1; SMN2MAPTALDH1A1MEN1 | |
| SCHEMBL16769411 | 0.88 | RAB9A (0.45) | RAB9ASMN1; SMN2MAPTALDH1A1MEN1 | |
| SCHEMBL16769428 | 0.86 | RAB9A (0.49) | RAB9ASMN1; SMN2MAPTALDH1A1MEN1 | |
| SCHEMBL16769418 | 0.86 | RAB9A (0.49) | RAB9ASMN1; SMN2MAPTALDH1A1MEN1 | |
| SCHEMBL12622324 | 0.86 | RAB9A (0.57) | RAB9ASMN1; SMN2MAPTALDH1A1MEN1 | |
| SCHEMBL11976539 | 0.85 | ALDH1A1 (0.58) | RAB9ASMN1; SMN2MAPTALDH1A1MEN1 | |
| SCHEMBL11927622 | 0.85 | ALDH1A1 (0.58) | RAB9ASMN1; SMN2MAPTALDH1A1MEN1 | |
| SCHEMBL11976562 | 0.85 | RAB9A (0.51) | RAB9ASMN1; SMN2MAPTALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9905767-B2 | High-molecular compound and light-emitting element using same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-02-27 | — | — | US | disclosed |
| US-9853218-B2 | High-molecular compound and light-emitting element using same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-12-26 | — | — | US | disclosed |
| US-20150207077-A1 | HIGH-MOLECULAR COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-07-23 | — | — | US | disclosed |
| US-20150155495-A1 | HIGH-MOLECULAR COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150155495-A1 | HIGH-MOLECULAR COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME | ARL1, CCNL2, CRKL | RAB9A 825/4885SMN1; SMN2 3233/4885MAPT 2720/4885 |
| US-20150207077-A1 | HIGH-MOLECULAR COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME | ARL1, GRK1, GNA11 | RAB9A 1031/4885SMN1; SMN2 2660/4885MAPT 3221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.